A Retrospective Cohort Study of the Risk of Severe Hepatoxicity in Hospitalized patients Treated with Echinocandins

Study identification

• EU PAS number:
  EUPAS14665
• Study ID:
  14666
• Official title and acronym:
  A Retrospective Cohort Study of the Risk of Severe Hepatoxicity in Hospitalized patients Treated with Echinocandins
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

No information provided.

Study timelines

Date when funding contract was signed

Planned:11/12/2013

Actual:12/03/2014

Study start date

Planned:15/12/2013

Actual:24/04/2014

Date of final study report

Planned:06/04/2015

Actual:20/04/2015

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Pfizer

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable